Final Results of a Non-Interventional Study Evaluating the Quality of Life in Second-line Treatment of Metastatic Renal Cell Carcinoma With Everolimus: The EVERPRO Study 16. April 2019 Goebell, P.J., Hermann, E., Kube, U., Doehn, C., Marschner, N., Dietel, A., Blumenstengel, K., Grimm, M.-O., Scheffler, M., Rogler, A., Bergmann, L. Oncol Res Treat 42(1–2). doi:10.1159/000494278 Prophylaxis of chemotherapy-induced neutropenia and febrile neutropenia with lipegfilgrastim in patients with non-Hodgkin lymphoma (NADIR study) Wolff, T., Schulz, H., Losem, C., Reichert, D., Hurtz, H.-J., Sandner, R., Harde, J., Grebhardt, S., Potthoff, K., Mueller, U., Fietz, T Eur J Haematol… Weiterlesen A novel prognostic score for patients with metastatic colorectal cancer Marschner, N., Frank, M., Vach, W., Ladda, E., Karcher, A., Winter, S., Jänicke, M., Trarbach, T. Colorectal Disease. doi:10.1111/codi.14600 Abstract… Weiterlesen